TLS as Predictors and Targets in Neoadjuvant Chemoimmunotherapy for NSCLC
Tertiary lymphoid structures (TLS) have emerged as critical modulators of antitumor immunity in non‐small cell lung cancer (NSCLC), with growing evidence supporting their role as both prognostic biomarkers and functional targets in neoadjuvant chemoimmunotherapy. TLS are organized ectopic lymphoid aggregates that facil...